Creative Planning Co Diagnostics, Inc. Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$8.12 - $10.37 $668,722 - $854,021	-82,355 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$7.48 - $11.38 $325,380 - $495,030	43,500 Added 111.95%	82,355 $801,000
Q2 2021 Aug 04, 2021	SELL	$7.16 - $9.56 $57,609 - $76,919	-8,046 Reduced 17.16%	38,855 $321,000
Q1 2021 Apr 30, 2021	BUY	$8.52 - $19.21 $243,629 - $549,309	28,595 Added 156.21%	46,901 $447,000
Q4 2020 Jan 29, 2021	SELL	$9.3 - $15.19 $139,035 - $227,090	-14,950 Reduced 44.95%	18,306 $170,000
Q3 2020 Nov 05, 2020	BUY	$8.24 - $30.8 $127,225 - $475,552	15,440 Added 86.66%	33,256 $452,000
Q2 2020 Jul 23, 2020	BUY	$7.46 - $23.42 $132,907 - $417,250	17,816 New	17,816 $345,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.